Literature DB >> 23669642

NF-κB activity is inversely correlated to RNF11 expression in Parkinson's disease.

Elaine Pranski1, Carson D Van Sanford, Nirjari Dalal, Adam L Orr, Dipan Karmali, Deborah S Cooper, Marla Gearing, James J Lah, Allan I Levey, Ranjita Betarbet.   

Abstract

RING finger protein 11 (RNF11), a negative regulator of NF-κB signaling pathway, colocalizes with α-synuclein and is sequestered in Lewy bodies in Parkinson's disease (PD). Since persistent NF-κB activation is reported in PD, in this report we investigated if RNF11 expression level is correlated to activated NF-κB in PD. We examined RNF11 expression levels in correlation to phospho-p65, a marker for activated NF-κB, in control and PD brain tissue from cerebral cortex. In addition we performed double immunofluorescence labeling experiments to confirm this correlation. Our investigations demonstrated that the neuronal RNF11 expression was down-regulated in PD and was usually associated with increased expression of phospho-p65. Double labeling confirmed that loss of neuronal RNF11 was linked to increased phospho-p65 expression, suggesting that persistent presence of NF-κB activation could be due to decreased levels of its negative regulator. Our data exemplifies the relevance of RNF11 and persistent NF-κB activation in PD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23669642      PMCID: PMC3699785          DOI: 10.1016/j.neulet.2013.04.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

Authors:  S Hunot; B Brugg; D Ricard; P P Michel; M P Muriel; M Ruberg; B A Faucheux; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 2.  Return to homeostasis: downregulation of NF-κB responses.

Authors:  Jürgen Ruland
Journal:  Nat Immunol       Date:  2011-06-19       Impact factor: 25.606

3.  Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.

Authors:  Elaine L Pranski; Carson D Van Sanford; Nirjari V Dalal; Adam L Orr; Dipan Karmali; Deborah S Cooper; Nichole Costa; Craig J Heilman; Marla Gearing; James J Lah; Allan I Levey; Ranjita S Betarbet
Journal:  Neurosci Lett       Date:  2012-05-23       Impact factor: 3.046

4.  Regulator of G-protein signaling-10 negatively regulates NF-κB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats.

Authors:  Jae-Kyung Lee; Jaegwon Chung; Fiona E McAlpine; Malú G Tansey
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

5.  The soluble form of Fas molecule is elevated in parkinsonian brain tissues.

Authors:  M Mogi; M Harada; T Kondo; Y Mizuno; H Narabayashi; P Riederer; T Nagatsu
Journal:  Neurosci Lett       Date:  1996-12-20       Impact factor: 3.046

Review 6.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

7.  Fas-associated factor 1 and Parkinson's disease.

Authors:  Ranjita Betarbet; Leah R Anderson; Marla Gearing; Tiffany R Hodges; Jason J Fritz; James J Lah; Allan I Levey
Journal:  Neurobiol Dis       Date:  2008-05-29       Impact factor: 5.996

8.  Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.

Authors:  Anamitra Ghosh; Avik Roy; Xiaojuan Liu; Jeffrey H Kordower; Elliott J Mufson; Dean M Hartley; Sankar Ghosh; R Lee Mosley; Howard E Gendelman; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

9.  PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain.

Authors:  Leah R Anderson; Ranjita Betarbet; Marla Gearing; Jeffrey Gulcher; Andrew A Hicks; Kári Stefánsson; James J Lah; Allan I Levey
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

10.  The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.

Authors:  Noula Shembade; Kislay Parvatiyar; Nicole S Harhaj; Edward W Harhaj
Journal:  EMBO J       Date:  2009-01-08       Impact factor: 11.598

View more
  13 in total

1.  A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

Authors:  Simona Perga; Serena Martire; Francesca Montarolo; Nicole D Navone; Andrea Calvo; Giuseppe Fuda; Alberto Marchet; Daniela Leotta; Adriano Chiò; Antonio Bertolotto
Journal:  Neurotox Res       Date:  2017-03-23       Impact factor: 3.911

Review 2.  Critical Roles of Glutaredoxin in Brain Cells-Implications for Parkinson's Disease.

Authors:  Olga Gorelenkova Miller; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2018-01-05       Impact factor: 8.401

3.  Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Gvindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Iuliia Dubova; Gema Giler; Shelby Herr; Shankar S Iyer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

Review 4.  Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.

Authors:  Mohammad Rafi Khezri; Morteza Ghasemnejad-Berenji
Journal:  Neurochem Res       Date:  2022-07-08       Impact factor: 4.414

Review 5.  NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.

Authors:  Annamaria Lanzillotta; Vanessa Porrini; Arianna Bellucci; Marina Benarese; Caterina Branca; Edoardo Parrella; Pier Franco Spano; Marina Pizzi
Journal:  Front Neurol       Date:  2015-05-20       Impact factor: 4.003

Review 6.  The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes.

Authors:  Asghar Abbasi; Kirsi Forsberg; Felix Bischof
Journal:  Front Mol Neurosci       Date:  2015-06-15       Impact factor: 5.639

7.  Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.

Authors:  Matthew D Li; Terry C Burns; Alexander A Morgan; Purvesh Khatri
Journal:  Acta Neuropathol Commun       Date:  2014-09-04       Impact factor: 7.801

8.  Ring Finger Protein 11 (RNF11) Modulates Dopamine Release in Drosophila.

Authors:  Eve Privman Champaloux; Nathan Donelson; Poojan Pyakurel; Danielle Wolin; Leah Ostendorf; Madelaine Denno; Ryan Borman; Chris Burke; Jonah C Short-Miller; Maria R Yoder; Jeffrey M Copeland; Subhabrata Sanyal; B Jill Venton
Journal:  Neuroscience       Date:  2020-11-08       Impact factor: 3.590

9.  Upregulation of human PINK1 gene expression by NFκB signalling.

Authors:  Xiaoling Duan; Jade Tong; Qin Xu; Yili Wu; Fang Cai; Tingyu Li; Weihong Song
Journal:  Mol Brain       Date:  2014-08-11       Impact factor: 4.041

10.  MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11.

Authors:  Usama Ashraf; Bibo Zhu; Jing Ye; Shengfeng Wan; Yanru Nie; Zheng Chen; Min Cui; Chong Wang; Xiaodong Duan; Hao Zhang; Huanchun Chen; Shengbo Cao
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.